Local pharmaceutical entrepreneur Jay Bhaumik is entering his next era with BMK Pharma. The forthcoming 50,000-square-foot ...
When patients are prescribed complex therapies — like specialty drugs, cell and gene treatments, or high-cost biologics — the path to treatment is rarely straightforward. Filling a prescription can ...
In 2022, the combined research and development (R&D) expenditure of the U.S. pharmaceutical industry consisted of more than $100 billion. While this is a significantly expansive market, approximately ...
The pharmaceutical industry has immense pressure to deliver advanced and novel therapies to patients worldwide but faces monumental challenges in drug development. On average, the journey from ...
You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Rebecca Torrence Every time Rebecca publishes a story, you’ll get an alert straight to your ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. In recent years, pharmaceutical companies have broadened their horizons, moving beyond drug ...
Gland Pharma Ltd (NSE:GLAND) reports a 6% revenue increase, driven by US market performance and strategic product launches.
A little over a decade ago, a class of drugs to treat blood cancers arrived on the scene. Known as BTK inhibitors, they block a key enzyme needed by cancer cells to survive. “These drugs turn the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback